Cited by 121Antifungal resistance and susceptibilityFungal and yeast genetics researchBacterial biofilms and quorum sensing

Candida albicans biofilms: building a heterogeneous, drug-tolerant environment

Bonhomme, Julie, d’Enfert, Christophe·2013·Current Opinion in Microbiology

Abstract

Fungi are able to form biofilms on medical implants, causing serious infections. A better understanding of fungal biofilm formation is necessary to develop tools for detection or prevention and to identify new antifungal strategies. This review explores recent advances in the characterization at the molecular level of fungal biofilms, especially those formed by the yeast Candida albicans: the identification of complex transcriptional networks that control their formation; the pivotal role of the extracellular matrix in biofilm antifungal tolerance; and the knowledge gained on the physiology of biofilm cells and heterogeneity within these communities. These findings may help develop new, targeted therapeutic strategies.

Integrity signals

Registry

Crossref · 10.1016/j.mib.2013.03.007

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In addition to the 6 master transcriptional regulators, another 44 transcriptional regulators have been identified; if any is deleted, some aspect of C. albicans biofilm formation is affected under at least one condition.

    “In addition to the 6 master transcriptional regulators discussed above, another 44 transcriptional regulators have been identified; if any of these is deleted, some aspect of C. albicans biofilm formation is affected under at least one condition (Table 1; revised from 61 and 18).”

    From <i>Candida albicans</i> Biofilms and Human Disease (2015) · cites this paper as [18]

  • Current antifungal drugs have only two specific targets: ergosterol biosynthesis and 1,3-β-D-glucan synthesis.

    “Current antifungal drugs have only two specific targets (ergosterol biosynthesis and 1,3-β-D-glucan synthesis)”

    From <i>Candida albicans</i> Biofilms and Human Disease (2015) · cites this paper as [18]

  • It is widely believed that antifungal drugs with new mechanisms of action are needed.

    “and it is widely believed that antifungal drugs with new mechanisms of action are needed (4, 18, 79).”

    From <i>Candida albicans</i> Biofilms and Human Disease (2015) · cites this paper as [18]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Bonhomme, J., & d’Enfert, C.
Affiliations
  • Centre Hospitalier Universitaire de Caen Normandie (FR)
  • Institut Pasteur (FR)
Corresponding author
d’Enfert, Christophe
Venue
Current Opinion in Microbiology
Publisher
Elsevier BV
Published
2013-08
Volume
16
Issue
4
Pages
398-403
ISSN
1369-5274 (ISSN-L)
OpenAlex
W2077255553
Cited by
120
References
53
Citations by year
2026: 3 · 2025: 8 · 2024: 7 · 2023: 7 · 2022: 1 · 2021: 8 · 2020: 4 · 2019: 11 · 2018: 11 · 2017: 9 · 2016: 12 · 2015: 16 · 2014: 16 · 2013: 6 · 2012: 1
FWCI
2.21
Type
journal article
Language
en
Open access
closed
Locations
  • Current Opinion in Microbiology (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion)
Funders
  • Agence Nationale de la Recherche (ANR-08-MIE-033-01, ANR-10-01)
  • French Government's Investissement d’Avenir program, Laboratoire d’Excellence (ANR-10-LABX-62-IBEID)
  • European Commission (PITN-GA-2008-214004)
  • Fondation pour la Recherche Médicale (DEA20080713005)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
Keywords
Candida albicans, fungal biofilms, biofilm heterogeneity, antifungal drug tolerance, extracellular matrix, transcriptional regulatory networks, biofilm physiology, medical device infections
MeSH terms
Antifungal Agents, Candida albicans, Drug Tolerance, Biofilms

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review